MICHELLE CURRAN: Open Payments
NPI 1841060803 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 27 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $563 · 2025 $600
Food & beverage: $600
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $126 |
| Aimmune Therapeutics, Inc. | 4 | $82 |
| Lilly USA, LLC | 3 | $77 |
| Novo Nordisk Inc | 3 | $65 |
| ABBVIE INC. | 3 | $62 |
| PFIZER INC. | 2 | $48 |
| Pulmonx Corporation | 1 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Paratek Pharmaceuticals, Inc. | 2 | $30 |
| Hologic Sales and Service, LLC | 1 | $28 |
Products named: AIRSUPRA, MOUNJARO, QULIPTA, ZENPEP, BREZTRI, PREVNAR 20, Ozempic, CHARTIS CATHETER.
Industry payments across MA — which companies pay providers there.
